Portfolio Main Image

Portfolio

Since 2024 we invested in the following startups

Category
Company
Description
First Partnered
Restari
Commercializing the first intravascular treatment procedure for acute kidney injury. Acute kidney injury have currently no approved treatments.
Seed / 2024
Wisy Platforms
Wisy harnesses data-driven insights to revolutionize retail execution for brands, delivering exceptional results and driving success.
Seed / 2024
QCentroid
QuantumOps Platform bridges the gap between quantum potential and real-world impact, enabling seamless adoption, integration, and scalability.
Seed / 2024